We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.07B
AUM Growth
-$441M
Cap. Flow
-$81M
Cap. Flow %
-3.92%
Top 10 Hldgs %
24.52%
Holding
315
New
9
Increased
84
Reduced
155
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 27.57%
2 Healthcare 25.36%
3 Industrials 14.78%
4 Consumer Discretionary 12.93%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENSG icon
151
The Ensign Group
ENSG
$10.7B
$2.83M 0.14%
38,558
-3,494
-8% -$279K
USPH icon
152
US Physical Therapy
USPH
$1.22B
$2.81M 0.14%
25,693
+182
+0.7% +$19.3K
LUCK
153
Lucky Strike Entertainment
LUCK
$911M
$2.8M 0.14%
264,440
-1,794
-0.7% -$19.1K
THRY icon
154
Thryv Holdings
THRY
$108M
$2.79M 0.13%
124,518
-46
-0% -$1.18K
ALG icon
155
Alamo Group
ALG
$2.05B
$2.78M 0.13%
23,851
+2,997
+14% +$367K
TBRG
156
DELISTED
TruBridge
TBRG
$2.77M 0.13%
86,586
+2,365
+3% +$76.5K
SEAT icon
157
Vivid Seats
SEAT
$85.4M
$2.74M 0.13%
18,368
+5,611
+44% +$1.02M
HAYN
158
DELISTED
Haynes International, Inc.
HAYN
$2.73M 0.13%
83,327
+11,459
+16% +$444K
PNTG icon
159
Pennant Group
PNTG
$1.36B
$2.71M 0.13%
211,715
+105,847
+100% +$1.76M
FIVE icon
160
Five Below
FIVE
$13.5B
$2.71M 0.13%
23,868
-830
-3% -$119K
ALNT icon
161
Allient
ALNT
$1.92B
$2.7M 0.13%
118,329
-111
-0.1% -$2.73K
PLOW icon
162
Douglas Dynamics
PLOW
$1.02B
$2.69M 0.13%
+93,669
New +$2.91M
EW icon
163
Edwards Lifesciences
EW
$51.7B
$2.65M 0.13%
27,902
-977
-3% -$101K
CCRD
164
DELISTED
CoreCard
CCRD
$2.64M 0.13%
108,052
-98
-0.1% -$2.31K
LASR icon
165
nLIGHT
LASR
$3.17B
$2.6M 0.13%
+254,455
New +$3.29M
CW icon
166
Curtiss-Wright
CW
$25.5B
$2.59M 0.13%
19,636
-2,384
-11% -$339K
IRMD icon
167
iRadimed
IRMD
$1.18B
$2.58M 0.12%
76,044
-5,072
-6% -$182K
DBI icon
168
Designer Brands
DBI
$333M
$2.56M 0.12%
196,382
+1,916
+1% +$27.6K
CVET
169
DELISTED
Covetrus, Inc. Common Stock
CVET
$2.56M 0.12%
123,334
-4,129
-3% -$73.5K
VMC icon
170
Vulcan Materials
VMC
$36.9B
$2.52M 0.12%
17,736
-275
-2% -$45.4K
EHC icon
171
Encompass Health
EHC
$12.4B
$2.5M 0.12%
56,174
-548
-1% -$28.1K
TVTX icon
172
Travere Therapeutics
TVTX
$5.78B
$2.47M 0.12%
101,991
+2,428
+2% +$61.1K
PRMW
173
DELISTED
Primo Water Corporation
PRMW
$2.44M 0.12%
182,514
-1,987
-1% -$28K
NATR icon
174
Nature's Sunshine
NATR
$288M
$2.43M 0.12%
227,471
+289
+0.1% +$4.02K
BRKR icon
175
Bruker
BRKR
$8.14B
$2.42M 0.12%
38,573
-582
-1% -$35.7K

Similar funds

Rice Hall James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Rice Hall James & Associates held 315 positions worth $2.07B, down 18% from $2.51B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $81M in Q2 2022, closing 50 positions and reducing 155 holdings. Its most notable exit was Mimecast Limited, an estimated $19.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Albany International worth $4.99M.

  • Rice Hall James & Associates's largest Q2 2022 buy was Albany International: 63,306 shares worth $4.99M.
  • Rice Hall James & Associates added most to Digital Turbine in Q2 2022, an estimated $30.2M increase.
  • Rice Hall James & Associates's biggest Q2 2022 reduction was Silicon Motion, cutting an estimated $26.3M.
  • Rice Hall James & Associates fully exited Mimecast Limited in Q2 2022, selling an estimated $19.2M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.07B portfolio in Q2 2022.
  • Rice Hall James & Associates opened 9 new positions and closed 50 in Q2 2022.
  • Rice Hall James & Associates's portfolio value fell 18% quarter-over-quarter to $2.07B.

Based on Rice Hall James & Associates's 13F filing for Q2 2022, filed 8 Aug 2022.